Abstract:Objective: To investigate the effects of miRNA-mediated down-regulation of the Bcl-2 gene on the chemotherapeutic sensitivities and mRNA transcriptions of sensitivity associated genes in human lung adenocarcinoma cell line A549 cells, and therefore to provide experimental data for improving the chemotherapeutic effects on non-small cell lung cancer (NSCLC). Methods: The miRNA recombinant plasmid targeting to human Bcl-2 gene was designed, synthesized and stably transferred into A549 cells by lipofectin technique as the experiment group. The transcription of Bcl-2 mRNA was detected by reverse transcription-polymerase chain reaction (RT-PCR) by agarose gel electrophoresis, real-time PCR, and the protein level of Bcl-2 was measured by Western blot to confirm the function of miRNA plasmid. The cell proliferation was examined by methyl thiazolyl tetrazolium (MTT) assay. Cell cycle was measured by flow cytometry. Drug sensitivities of A549 cells to etoposide, 5-fluorouracil, cisplatin, adriamycin, vincristine, paclitaxel and navelbine were analyzed by MTT assay. The mRNA expressions of excision repair cross-complementing gene 1 (ERCC1), thymidylate synthase (TYMS), Class III β-tubulin, topoisomerase 2 alpha (TOP2α) genes were detected by RT-PCR and real-time PCR. Results: The recombinant miRNA plasmid was successfully synthesized and stably transferred into A549 cells. The transcription of Bcl-2 mRNA dramatically decreased by 98.1% in the experiment group (RQ = 0.002 ± 0.001) compared to that in the negative control group (RQ = 0.104 ± 0.003) by real-time PCR (t = 98.70, P < 0.05); and the protein level of Bcl-2 in the experiment group decreased by 57.6% by Western blot (t = 7.66, P < 0.05). The cell cycle profile showed that the low expression of Bcl-2 gene led to A549 cell cycle arrest at G1-phase. The results of MTT showed that the growth of A549 cells in the experiment group was markedly inhibited. The sensitivities of A549 cells to etoposide, cisplatin, paclitaxel, and navelbine were significantly enhanced [IC₅₀ values in the experiment group were (107.3 ± 0.1) mg/L, (7.7 ± 0.6) mg/L, (11.5 ± 1.9) mg/L and (10.8 ± 1.6) mg/L; IC₅₀ values in the negative control group were (145.8 ± 0.1) mg/L, (60.7 ± 1.4) mg/L, (80.6 ± 1.7) mg/L and (20.6 ± 1.7) mg/L], the respective t values being 655.33, 108.04, 82.16 and 12.48, all P < 0.05. The mRNA level of ERCC1, TYMS, and TOP2α genes in the experiment group decreased by 99.6%, 92.9% and 96.1% respectively, but Class III β-tubulin mRNA increased by 122% compared to the negative control group (1.154 ± 0.008, 0.520 ± 0.009), the respective t values being 689.79, 689.37, 768.04 and 160.07, all P < 0.05. Conclusion: Targeting to inhibit antiapoptotic mitochondrial gene Bcl-2 expression in A549 cells specifically decreased the mRNA of ERCC1, TYMS, and TOP2α genes, and significantly increased the sensitivities of A549 cells to chemotherapeutic agents such as etoposide, cisplatin, paclitaxel and navelbine.

Effects of microRNA-134 on proliferation and apoptosis of non-small cell lung cancer by regulating P53 protein

Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer

Effect and Molecular Mechanism of Mir-146A on Proliferation of Lung Cancer Cells by Targeting and Regulating MIF Gene

Mir‑654‑3p Suppresses Cell Viability and Promotes Apoptosis by Targeting RASAL2 in Non‑small‑cell Lung Cancer.

miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor.

MicroRNA-34a Inhibits the Proliferation and Promotes the Apoptosis of Non-Small Cell Lung Cancer H1299 Cell Line by Targeting TGFβR2

Effect of miR-335 upregulation on the apoptosis and invasion of lung cancer cell A549 and H1299

Mir-145 Suppresses the Proliferation, Invasion and Migration of NSCLC Cells by Regulating the BAX/BCL-2 Ratio and the Caspase-3 Cascade

Effects of miR-1253 on proliferation,migration and invasion of lung adenocarcinoma cells

microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.

MicroRNA-134 regulates lung cancer cell H69 growth and apoptosis by targeting WWOX gene and suppressing the ERK1/2 signaling pathway

Hsa-miR-134 Suppresses Non-Small Cell Lung Cancer (NSCLC) Development Through Down-Regulation of CCND1

Expression and Effect of Mir-769-5p on Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer

Up-regulated miR-196a promotes non-small cell lung cancer cells proliferation by regulating p27~(kip1) expression

MicroRNA-15a Induces Cell Apoptosis and Inhibits Metastasis by Targeting BCL2L2 in Non-Small Cell Lung Cancer

MicroRNA‑365b‑3p Represses the Proliferation and Promotes the Apoptosis of Non‑small Cell Lung Cancer Cells by Targeting PPP5C

Effect of Pterostilbene on Regulating LncRNA-Linc00511 Targeting MiR-184 to Promote the Proliferation and Invasion of Non-Small Cell Lung Cancer Under Hypoxic Environment

[The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs]

Effect of Microrna-143-3p-mediated CTNND1 on the Biological Function of Lung Cancer Cells

MicroRNA-17-5p Inhibits Proliferation and Triggers Apoptosis in Non-Small Cell Lung Cancer by Targeting Transforming Growth Factor Β Receptor 2.

The Effect of MicroRNA-409-3p for Treatment and Response to Tumor Proliferation of Lung Cancer Cell Lines (In Vitro)